Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Charbel Issa

Showing results (31-40 of 231) with videos related to

Pageof 24
Sort By:
Retina (Philadelphia, Pa.)|December 20, 2013
First symptoms and their age of onset in macular telangiectasia type 2Tjebo F C Heeren, Frank G Holz, Peter Charbel Issa
Retinal Cases & Brief Reports|November 13, 2014
Short-term effects of intravitreal bevacizumab in type ii idiopathic macular telangiectasiaPeter Charbel Issa, Hendrik P N Scholl, Frank G Holz
Retinal Cases & Brief Reports|November 13, 2014
Short-term effects of intravitreal bevacizumab in type 2 idiopathic macular telangiectasiaPeter Charbel Issa, Hendrik P N Scholl, Frank G Holz
The British Journal of Ophthalmology|June 25, 2021
Morphological characteristics preceding exudative neovascularisation secondary to macular telangiectasia type 2Kristina Hess, Peter Charbel Issa, Frank G Holz, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|December 4, 2010
The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical applicationPeter Charbel Issa, N Victor Chong, Hendrik P N Scholl
Ophthalmology|September 8, 2007
Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasiaPeter Charbel Issa, Frank G Holz, Hendrik P N Scholl
Documenta Ophthalmologica. Advances in Ophthalmology|August 28, 2009
Metamorphopsia in patients with macular telangiectasia type 2Peter Charbel Issa, Frank G Holz, Hendrik P N Scholl
Eye (London, England)|April 12, 2024
Dropless After Cataract Surgery (DACS) for patients with difficulties using eye dropsJohannes Birtel, Guy Mole, Sher A Aslam, et al.
Klinische Monatsblatter Fur Augenheilkunde|January 27, 2025
[Correction: Differential diagnosis of age-related macular degeneration]Peter Charbel Issa, Samantha R De Silva, Kristina Pfau, et al.
Journal of Genetic Syndromes & Gene Therapy|February 28, 2017
A fragmented adeno-associated viral dual vector strategy for treatment of diseases caused by mutations in large genes leads to expression of hybrid transcriptsMichelle E McClements, Peter Charbel Issa, Véronique Blouin, et al.
Pageof 24

Showing results (31-40 of 231) with videos related to

Sort By:
Pageof 24
Retina (Philadelphia, Pa.)|December 20, 2013
First symptoms and their age of onset in macular telangiectasia type 2Tjebo F C Heeren, Frank G Holz, Peter Charbel Issa
Retinal Cases & Brief Reports|November 13, 2014
Short-term effects of intravitreal bevacizumab in type ii idiopathic macular telangiectasiaPeter Charbel Issa, Hendrik P N Scholl, Frank G Holz
Retinal Cases & Brief Reports|November 13, 2014
Short-term effects of intravitreal bevacizumab in type 2 idiopathic macular telangiectasiaPeter Charbel Issa, Hendrik P N Scholl, Frank G Holz
The British Journal of Ophthalmology|June 25, 2021
Morphological characteristics preceding exudative neovascularisation secondary to macular telangiectasia type 2Kristina Hess, Peter Charbel Issa, Frank G Holz, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|December 4, 2010
The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical applicationPeter Charbel Issa, N Victor Chong, Hendrik P N Scholl
Ophthalmology|September 8, 2007
Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasiaPeter Charbel Issa, Frank G Holz, Hendrik P N Scholl
Documenta Ophthalmologica. Advances in Ophthalmology|August 28, 2009
Metamorphopsia in patients with macular telangiectasia type 2Peter Charbel Issa, Frank G Holz, Hendrik P N Scholl
Eye (London, England)|April 12, 2024
Dropless After Cataract Surgery (DACS) for patients with difficulties using eye dropsJohannes Birtel, Guy Mole, Sher A Aslam, et al.
Klinische Monatsblatter Fur Augenheilkunde|January 27, 2025
[Correction: Differential diagnosis of age-related macular degeneration]Peter Charbel Issa, Samantha R De Silva, Kristina Pfau, et al.
Journal of Genetic Syndromes & Gene Therapy|February 28, 2017
A fragmented adeno-associated viral dual vector strategy for treatment of diseases caused by mutations in large genes leads to expression of hybrid transcriptsMichelle E McClements, Peter Charbel Issa, Véronique Blouin, et al.
Pageof 24